Has Juanita Dee received payments from drug or device companies?

Yes. Drug and device makers reported $3,130 in general payments to Juanita Dee across 101 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Juanita Dee did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Juanita Dee come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Juanita Dee

Family · Wallingford, CTNPI 1609344480

Payments from drug & device makers

$3,130in general payments, 2019–2025

Across 101 payments — averaging $30.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$608
Johnson & Johnson$442
Otsuka America Pharmaceutical, Inc.$368
Alkermes, Inc.$343
USWM, LLC$270
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$164
plus $936 from 15 others

What the payments were for

Food & beverage$3,130100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	24	$608
Johnson & Johnson	18	$442
Otsuka America Pharmaceutical, Inc.	3	$368
Alkermes, Inc.	3	$343
USWM, LLC	15	$270
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	3	$164
Collegium Pharmaceutical, Inc.	2	$136
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	15	$133
Teva Pharmaceuticals USA, Inc.	2	$131
Vanda Pharmaceuticals Inc.	1	$125
E.r. Squibb & Sons, L.L.C.	2	$119
Neurelis, Inc.	3	$88
Pfizer	2	$44
Neurocrine Biosciences, Inc.	1	$23
Gilead	1	$23
Jazz Pharmaceuticals Inc.	1	$21
Orexo US, Inc.	1	$21
Biohaven Pharmaceuticals, Inc.	1	$21
Scilex Pharmaceuticals Inc.	1	$20
GSK	1	$17
Boehringer Ingelheim	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,130 in reported general payments places this provider in the 85th percentile of 1,596 family providers in Connecticut.

See all family providers in Connecticut →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
ProliaDenosumab	39	$75,134
LinzessLinaclotide	109	$65,896
Divalproex Sodium	163	$20,987
EliquisApixaban	27	$16,423
Carbamazepine	119	$12,354
Rufinamide	13	$11,904
Levetiracetam	152	$9,571
Topiramate	96	$7,899
Valproic AcidValproic Acid (As Sodium Salt)	65	$7,050
GemtesaVibegron	14	$6,825
Lactulose	133	$5,994
Pantoprazole Sodium	47	$5,966
Lamotrigine	196	$5,808
Omeprazole	258	$5,357
Tamsulosin Hcl	207	$5,134

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
AbbVieLinzess	$608	$65,896109 claims
PfizerEliquis	$44	$16,42327 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,596 family providers in Connecticut.

Other family in Wallingford

Hilary SullivanWallingford$18K
Ursula HoxieWallingford$14K
Alexandria ViscosiWallingford$12K
Elisha ChristiansonWaterbury$371K
Kathryn TierneyNew Britain$140K
Jennifer SilvaSouth Windsor$91K
Carli WillardEnfield$74K
Erin MartinMilford$70K
Dayna GiordanoNew Haven$65K
Diana BytyqiDerby$53K

See the full list for Connecticut →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →